MDIC released a Request for Information (RFI) on March 30, 2019. We are requesting technical information about available and possible approaches for creating a set of human cell lines that include all–or subsets of– specific variants. The variants were drawn from a larger list developed by the MDIC SRS working group and include clinically actionable oncogene variants as defined by (1) those that are included in companion diagnostic labels or described in NCCN guidelines (Level 1) or(2) variants included in registrational trials (Level 2). Please note that MDIC SRS is also interested to incorporate variants in tumor suppressor genes into a possible set of future reference samples.
The RFI is available for download in MDIC’s Resource Library.
A webinar will be held on Thursday, April 4 at 4:00 pm ET for Q&A on the RFI. For more information click here.